US Stock MarketDetailed Quotes

Dermata Therapeutics (DRMA)

Watchlist
  • 1.240
  • -0.025-1.98%
Close Apr 24 16:00 ET
  • 1.250
  • +0.010+0.81%
Post 19:18 ET
4.99MMarket Cap-0.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dermata Therapeutics (DRMA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.51%-7.76M
54.38%-1.33M
47.24%-1.8M
-26.55%-2.69M
28.49%-1.93M
-74.18%-11.16M
-153.95%-2.91M
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
Net income from continuing operations
38.49%-7.56M
40.91%-1.86M
46.68%-1.69M
39.87%-1.7M
26.50%-2.3M
-57.64%-12.29M
-47.66%-3.15M
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
Change In working capital
-173.41%-342.73K
142.51%503.22K
43.90%-149.67K
-250.48%-1.03M
311.10%332.33K
-45.94%466.86K
-75.82%207.51K
-45.30%-266.76K
353.00%683.55K
-134.28%-157.43K
-Change in prepaid assets
-81.88%30.47K
-61.80%65.44K
33.22%-247.7K
-53.85%126.15K
-8.31%86.58K
3.37%168.18K
13.13%171.28K
11.17%-370.9K
7.63%273.38K
-46.00%94.42K
-Change in payables and accrued expense
-224.95%-373.2K
1,108.25%437.79K
-5.86%98.03K
-381.54%-1.15M
197.58%245.75K
-57.39%298.68K
-94.87%36.23K
-55.49%104.13K
178.25%410.17K
-188.55%-251.85K
Cash from discontinued investing activities
Operating cash flow
30.51%-7.76M
54.38%-1.33M
47.24%-1.8M
-26.55%-2.69M
28.49%-1.93M
-74.18%-11.16M
-153.95%-2.91M
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
75.97%12.12M
6,206.42%4.19M
-100.28%-12.99K
-123.42%-547.86K
8.49M
-9.46%6.89M
-103.51%-68.57K
13,131.36%4.62M
54.71%2.34M
0
Net common stock issuance
76.72%12.17M
6,123.75%4.19M
-100.29%-12.99K
-122.74%-547.86K
--8.54M
-9.47%6.89M
-103.56%-69.51K
12,933.26%4.55M
59.34%2.41M
--0
Proceeds from stock option exercised by employees
-11.90%977
--0
--0
--0
--977
493.05%1.11K
--941
--168
--0
--0
Net other financing activities
---50.5K
--0
--0
--0
---50.5K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
75.97%12.12M
6,206.42%4.19M
-100.28%-12.99K
-123.42%-547.86K
--8.49M
-9.46%6.89M
-103.51%-68.57K
13,131.36%4.62M
54.71%2.34M
--0
Net cash flow
Beginning cash position
-57.50%3.16M
-24.08%4.66M
31.00%6.48M
105.32%9.72M
-57.50%3.16M
19.18%7.44M
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
Current changes in cash
201.96%4.36M
195.83%2.86M
-251.82%-1.82M
-1,617.36%-3.24M
342.48%6.56M
-457.32%-4.28M
-469.70%-2.98M
166.22%1.2M
165.02%213.42K
-207.09%-2.7M
End cash Position
137.92%7.52M
137.92%7.52M
-24.08%4.66M
31.00%6.48M
105.32%9.72M
-57.50%3.16M
-57.50%3.16M
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
Free cash flow
30.51%-7.76M
54.38%-1.33M
47.24%-1.8M
-26.55%-2.69M
28.49%-1.93M
-74.18%-11.16M
-153.95%-2.91M
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.51%-7.76M54.38%-1.33M47.24%-1.8M-26.55%-2.69M28.49%-1.93M-74.18%-11.16M-153.95%-2.91M-92.98%-3.42M-15.52%-2.13M-63.94%-2.7M
Net income from continuing operations 38.49%-7.56M40.91%-1.86M46.68%-1.69M39.87%-1.7M26.50%-2.3M-57.64%-12.29M-47.66%-3.15M-84.57%-3.17M-66.28%-2.83M-39.91%-3.13M
Change In working capital -173.41%-342.73K142.51%503.22K43.90%-149.67K-250.48%-1.03M311.10%332.33K-45.94%466.86K-75.82%207.51K-45.30%-266.76K353.00%683.55K-134.28%-157.43K
-Change in prepaid assets -81.88%30.47K-61.80%65.44K33.22%-247.7K-53.85%126.15K-8.31%86.58K3.37%168.18K13.13%171.28K11.17%-370.9K7.63%273.38K-46.00%94.42K
-Change in payables and accrued expense -224.95%-373.2K1,108.25%437.79K-5.86%98.03K-381.54%-1.15M197.58%245.75K-57.39%298.68K-94.87%36.23K-55.49%104.13K178.25%410.17K-188.55%-251.85K
Cash from discontinued investing activities
Operating cash flow 30.51%-7.76M54.38%-1.33M47.24%-1.8M-26.55%-2.69M28.49%-1.93M-74.18%-11.16M-153.95%-2.91M-92.98%-3.42M-15.52%-2.13M-63.94%-2.7M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 75.97%12.12M6,206.42%4.19M-100.28%-12.99K-123.42%-547.86K8.49M-9.46%6.89M-103.51%-68.57K13,131.36%4.62M54.71%2.34M0
Net common stock issuance 76.72%12.17M6,123.75%4.19M-100.29%-12.99K-122.74%-547.86K--8.54M-9.47%6.89M-103.56%-69.51K12,933.26%4.55M59.34%2.41M--0
Proceeds from stock option exercised by employees -11.90%977--0--0--0--977493.05%1.11K--941--168--0--0
Net other financing activities ---50.5K--0--0--0---50.5K--------------------
Cash from discontinued financing activities
Financing cash flow 75.97%12.12M6,206.42%4.19M-100.28%-12.99K-123.42%-547.86K--8.49M-9.46%6.89M-103.51%-68.57K13,131.36%4.62M54.71%2.34M--0
Net cash flow
Beginning cash position -57.50%3.16M-24.08%4.66M31.00%6.48M105.32%9.72M-57.50%3.16M19.18%7.44M-7.35%6.14M-41.37%4.95M-46.00%4.73M19.18%7.44M
Current changes in cash 201.96%4.36M195.83%2.86M-251.82%-1.82M-1,617.36%-3.24M342.48%6.56M-457.32%-4.28M-469.70%-2.98M166.22%1.2M165.02%213.42K-207.09%-2.7M
End cash Position 137.92%7.52M137.92%7.52M-24.08%4.66M31.00%6.48M105.32%9.72M-57.50%3.16M-57.50%3.16M-7.35%6.14M-41.37%4.95M-46.00%4.73M
Free cash flow 30.51%-7.76M54.38%-1.33M47.24%-1.8M-26.55%-2.69M28.49%-1.93M-74.18%-11.16M-153.95%-2.91M-92.98%-3.42M-15.52%-2.13M-63.94%-2.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -